How Trump’s tariffs threaten Ireland’s pharma fortune
Failed to add items
Add to Cart failed.
Add to Wish List failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
How Trump’s tariffs threaten Ireland’s pharma fortune
-
Narrated by:
-
By:
About this listen
Ireland has become a major base for US pharma companies, including Pfizer, Eli Lilly and Johnson & Johnson. That’s bolstered the economies of individual towns and played a role in the country’s massive budget surplus. Now, US President Donald Trump’s tariff threats are bringing a dose of uncertainty. The FT’s Ireland correspondent Jude Webber traveled to the town where the world’s supply of Botox is produced to see what impact potential pharmaceutical tariffs might have on the country.
Clips from WKYC, The Journal, Bloomberg
- - - - - - - - - - - - - - - - - - - - - - - - - -
For further reading:
Trump tariffs bring furrowed brows to Ireland’s Botox town
Trump’s tariffs threaten Ireland’s pharma fortune
Ireland’s luxury problem: what to do with its €8.6bn surplus
- - - - - - - - - - - - - - - - - - - - - - - - - -
Follow Jude Webber on X (@jude_webber), or on Bluesky (@judewebber.bsky.social). Michela Tindera is on X (@mtindera07) and Bluesky (@mtindera.ft.com), or follow her on LinkedIn for updates about the show and more.
Read a transcript of this episode on FT.com
Hosted on Acast. See acast.com/privacy for more information.